Literature DB >> 12960498

Protective effect of thalidomide on endotoxin-induced liver injury.

Nobuyuki Enomoto1, Yoshiyuki Takei, Miyoko Hirose, Tsuneo Kitamura, Kenichi Ikejima, Nobuhiro Sato.   

Abstract

BACKGROUND: Activation of Kupffer cells by lipopolysaccharide (LPS) plays a pivotal role in the onset of pathophysiological events that occur during endotoxemia, and intracellular calcium concentration ([Ca2+]i) is involved in LPS-stimulated cytokine production. Tumor necrosis factor (TNF)-alpha is produced exclusively by the monocyte-macrophage lineage, which is mostly made up of Kupffer cells, and thalidomide has been shown to reduce TNF-alpha production from macrophages. However, there is increasing evidence that TNF-alpha may play a role in the initiation or progression of multiple organ failure syndrome. Therefore, the purpose of this work was to determine whether thalidomide could prevent LPS-induced liver injury.
METHODS: Rats were given a single oral dose of thalidomide (5 mg/kg). To assess the sensitization of Kupffer cells, LPS (5 or 10 mg/kg) was administered intravenously, and mortality, liver histology, and transaminases were evaluated 24 hr later. Kupffer cells were isolated 2 hr after thalidomide treatment. After the addition of LPS, [Ca2+]i was measured by using a microspectrofluorometer with the fluorescent indicator fura-2, and TNF-alpha was measured by enzyme-linked immunosorbent assay.
RESULTS: LPS caused focal necrosis with neutrophil infiltration in the liver. Moreover, LPS dramatically increased transaminases. These pathologic parameters and increases of serum transaminases were diminished markedly by thalidomide. In isolated Kupffer cells, LPS-induced increases in [Ca2+]i and TNF-alpha production were suppressed by treatment with thalidomide. To further explore the mechanism by which thalidomide directly abrogated Kupffer cell sensitivity to LPS, we determined the effect of thalidomide (5 microM) in vitro on LPS-induced [Ca2+]i response and TNF-alpha production. With the addition of thalidomide (5 microM) in vitro to the culture media for 2 hr before LPS, these parameters were suppressed.
CONCLUSIONS: Thalidomide prevents LPS-induced liver injury via mechanisms dependent on the suppression of TNF-alpha production from Kupffer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960498     DOI: 10.1097/01.ALC.0000078606.59842.01

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  5 in total

1.  Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.

Authors:  Nicholas G Theodorakis; Yining N Wang; Vyacheslav A Korshunov; Mary A Maluccio; Nicholas J Skill
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  An insight into the possible protective effect of pyrrolidine dithiocarbamate against lipopolysaccharide-induced oxidative stress and acute hepatic injury in rats.

Authors:  Hanan H Hagar
Journal:  Saudi Pharm J       Date:  2009-11-10       Impact factor: 4.330

3.  A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells.

Authors:  Hong Wei Yao; Jun Li; Ji Qiang Chen; Shu Yun Xu
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

4.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

5.  Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis.

Authors:  Peng Lv; Shelley Chireyath Paul; Yanjv Xiao; Shiquan Liu; Hesheng Luo
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.